Distance to Neurologist, PCP May Explain Alzheimer Disease Disparities
By Elana Gotkine HealthDay Reporter
FRIDAY, April 5, 2024 -- Distance to a neurologist and primary care physician may explain some of the disparities in Alzheimer disease and related dementia (AD/ADRD) outcomes, according to a study published online March 20 in Alzheimer's & Dementia.
Solmaz Amiri, Ph.D., from the Elson S. Floyd College of Medicine at Washington State University in Seattle, and colleagues generated round-trip distance between residences of decedents with AD/ADRD and the nearest neurologist and primary care physician in Washington state to examine whether distance to physicians explains some of the disparities in outcomes.
The researchers found that the overall mean distance was 17 and 4 miles to the nearest neurologist and primary care physician, respectively. Compared with non-Hispanic Whites, non-Hispanic American Indian and/or Alaska Native and Hispanic decedents would have had to travel 1.12 and 1.07 times farther, respectively, to reach the nearest neurologist. Compared with those in metropolitan areas, decedents in micropolitan, small town, and rural areas would have had to travel 2.12 to 4.01 times farther to reach the nearest neurologist and 1.14 to 3.32 times farther to reach the nearest primary care physician.
"Implementation of targeted interventions can help address barriers to health care access for AD/ADRD patients," the authors write. "Solutions may include addressing transportation barriers for patients, strategic planning for placement of future physician practices, providing mobile health care in underserved areas, increasing the dementia specialist physician workforce, developing dementia-related professional curricula for PCPs, and building awareness and education around AD/ADRD for the general population."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Cognitive Impairment Still Seen in Children, Teens With HIV
TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...
Warning Letters Can Reduce Quetiapine Overprescribing
MONDAY, April 29, 2024 -- For patients with dementia, letters warning primary care physicians (PCPs) regarding overprescribing can reduce quetiapine prescriptions, according to a...
Nursing Home Staff Shortages Tied to More Inappropriate Antipsychotic Use
FRIDAY, April 26, 2024 -- Nursing homes with staffing shortages have higher inappropriate antipsychotic medication use, particularly among nursing homes in severely deprived...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.